04/04/19
The NASDAQ 100 Pre Market Indicator is down 5 1 to 7 539 87 The total Pre Market volume is currently 7 586 096 shares traded The following are the most active stocks for the pre market session NIO Inc NIO is 0 16 at 5 47 with 1 460 057 shares traded NIO s
04/03/19
Sangamo Therapeutics Inc 160 SGMO and its partner Pfizer PFE announced encouraging interim data from the phase I II Alta study evaluating their gene therapy candidate SB 525 in patients with severe hemophilia A Data showed that the gene therapy candidate holds potential Shares
04/03/19
InvestorPlace Stock Market News Stock Advice amp Trading Tips The bulls tried to follow through on Monday s impressive bullishness but just couldn t make it happen After spending some time above and below the previous day s close the S amp P 500 ended yesterday s
04/03/19
Sangamo Therapeutics NASDAQ SGMO recently thrilled investors with an update for its experimental gene therapy It looks like SB 525 can help people with a rare bleeding disorder called hemophilia A but it isn t the only potential new treatment for this condition
04/03/19
The April episode of the Zacks Ultimate Strategy Session will be available for viewing no later than Wednesday April 10 Kevin Matras Kevin Cook Dr John Blank and Sheraz Mian will cover the investment landscape from several angles in this popular event Don t miss your chance to
04/02/19
Tuesday was a relatively calm day for the stock market with most of the broader benchmarks finishing with only small changes A high profile negative earnings report from one of the components of the Dow Jones Industrial Average sent that index lower but more broadly investors
04/02/19
In trading on Tuesday biotechnology shares were relative leaders up on the day by about 1 1 Leading the group were shares of Sangamo Therapeutics SGMO up about 27 1 and shares of Novavax NVAX up about 8 8 on the day Also showing relative strength are manufacturing shares
04/02/19
In trading on Tuesday the SPDR S amp P Biotech ETF XBI is outperforming other ETFs up about 1 4 on the day Components of that ETF showing particular strength include shares of Sangamo Therapeutics SGMO up about 27 1 and shares of Esperion Therapeutics ESPR up about 8 3 on
04/02/19
InvestorPlace Stock Market News Stock Advice amp Trading Tips A bevy of Sangamo Therapeutics news for Tuesday has SGMO stock flying high today Source Shutterstock Sangamo Therapeutics NASDAQ SGMO starts off the day by announcing a new deal to increase
04/02/19
Midway through trading Tuesday the Dow traded down 0 37 percent to 26 160 51 while the NASDAQ gained 0 08 percent to 7 835 00 The S amp P also fell dropping 0 1 percent to 2 864 40 Leading and Lagging Sectors On Tuesday the materials shares rose 0 1 percent Meanwhile
04/02/19
What happened Shares of Sangamo Therapeutics NASDAQ SGMO were soaring 30 9 higher as of 11 19 a m EDT on Tuesday The biotech and its partner Pfizer NYSE PFE just announced encouraging interim data from a phase 1 2 clinical study evaluating experimental gene
04/02/19
Following the market opening Tuesday the Dow traded down 0 28 percent to 26 183 67 while the NASDAQ declined 0 03 percent to 7 826 23 The S amp P also fell dropping 0 07 percent to 2 865 18 Leading and Lagging Sectors Tuesday morning the materials shares rose 0 6
04/02/19
The NASDAQ 100 Pre Market Indicator is down 3 38 to 7 475 04 The total Pre Market volume is currently 4 653 883 shares traded The following are the most active stocks for the pre market session NIO Inc NIO is 0 28 at 5 49 with 1 682 765 shares traded NIO s
03/28/19
The past year hasn t been easy for Sangamo Therapeutics NASDAQ SGMO CRISPR Therapeutics NASDAQ CRSP and their respective shareholders The market has cleaved billions from their market values even though they hardly did anything Both are going to have some
03/26/19
The stocks of biotechs focused on gene editing haven t performed very well recently Two have performed especially poorly Shares of Editas Medicine NASDAQ EDIT are down around 40 over the last 12 months while Sangamo Therapeutics NASDAQ SGMO stock plunged nearly 60
SGMO - Sangamo Therapeutics